These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 22898085
1. Prognostic factors and clinical outcomes in synovial sarcoma of the extremities. Wisanuyotin T, Radapat K, Sirichativapee W, Paholpak P, Kosuwon W, Sumnanoont C, Jeeravipoolvarn P. Asia Pac J Clin Oncol; 2013 Mar; 9(1):80-5. PubMed ID: 22898085 [Abstract] [Full Text] [Related]
2. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities. Sakabe T, Murata H, Konishi E, Takeshita H, Ueda H, Matsui T, Horie N, Yanagisawa A, Kubo T. Med Sci Monit; 2008 Jun; 14(6):CR305-310. PubMed ID: 18509273 [Abstract] [Full Text] [Related]
3. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma. Smith KB, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Kirwan JM, Zlotecki RA, Scarborough MT, Gibbs CP, Marcus RB. Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):150-7. PubMed ID: 21550181 [Abstract] [Full Text] [Related]
4. Synovial sarcoma involving skull base--a retrospective analysis of diagnosis and treatment of 21 cases in one institution. Ji T, Ma CY, Ow A, Wang LZ, Sun J, Zhang CP. Oral Oncol; 2011 Jul 01; 47(7):671-6. PubMed ID: 21641853 [Abstract] [Full Text] [Related]
5. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity]. Li Y, Niu XH, Xu HR. Zhonghua Wai Ke Za Zhi; 2011 Nov 01; 49(11):964-9. PubMed ID: 22333413 [Abstract] [Full Text] [Related]
6. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression. ten Heuvel SE, Hoekstra HJ, Bastiaannet E, Suurmeijer AJ. Appl Immunohistochem Mol Morphol; 2009 May 01; 17(3):189-95. PubMed ID: 18997619 [Abstract] [Full Text] [Related]
7. [Evaluation of prognostic factors for synovial sarcoma]. Du ZY, Guo W, Yang RL, Yan TQ, Li DS. Zhonghua Wai Ke Za Zhi; 2011 Nov 01; 49(11):991-4. PubMed ID: 22333419 [Abstract] [Full Text] [Related]
8. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. Guillou L, Benhattar J, Bonichon F, Gallagher G, Terrier P, Stauffer E, Somerhausen Nde S, Michels JJ, Jundt G, Vince DR, Taylor S, Genevay M, Collin F, Trassard M, Coindre JM. J Clin Oncol; 2004 Oct 15; 22(20):4040-50. PubMed ID: 15364967 [Abstract] [Full Text] [Related]
11. The outcomes and prognostic factors of patients with soft-tissue sarcoma. Kiatisevi P, Asavamongkolkul A, Phimolsarnti R, Waikakul S, Benjarassamerote S. J Med Assoc Thai; 2006 Mar 15; 89(3):334-42. PubMed ID: 16696417 [Abstract] [Full Text] [Related]
12. [Synovial sarcoma of the extremities. Results of surgical and multimodal therapy]. Ulmer C, Kettelhack C, Tunn PU, Reichardt P, Hohenberger P, Schlag PM. Chirurg; 2003 Apr 15; 74(4):370-4. PubMed ID: 12719879 [Abstract] [Full Text] [Related]
13. Synovial sarcoma: a review of 33 cases. Buck P, Mickelson MR, Bonfiglio M. Clin Orthop Relat Res; 1981 May 15; (156):211-5. PubMed ID: 6164515 [Abstract] [Full Text] [Related]
14. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan. Takenaka S, Ueda T, Naka N, Araki N, Hashimoto N, Myoui A, Ozaki T, Nakayama T, Toguchida J, Tanaka K, Iwamoto Y, Matsumine A, Uchida A, Ieguchi M, Kaya M, Wada T, Baba I, Kudawara I, Aoki Y, Yoshikawa H. Oncol Rep; 2008 Feb 15; 19(2):467-76. PubMed ID: 18202796 [Abstract] [Full Text] [Related]
15. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF. J Clin Oncol; 2000 May 15; 18(10):2087-94. PubMed ID: 10811674 [Abstract] [Full Text] [Related]
16. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hasegawa T, Yokoyama R, Matsuno Y, Shimoda T, Hirohashi S. Hum Pathol; 2001 Mar 15; 32(3):257-63. PubMed ID: 11274633 [Abstract] [Full Text] [Related]
17. Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology. Tarkan Y, Erkan A, Selcuk ES, Mehmet K, Tugba KF, Ozlem US, Suleyman A, Tulay A, Bilge A, Ramazan Y, Yusuf G, Mevlude I, Umut D, Ilhan O, Abdurrahman I, Alper S, Dogan U, Necati A, Berna O, Gok DA, Ugur Y, Mahmut G. J Cancer Res Ther; 2014 Mar 15; 10(1):73-8. PubMed ID: 24762490 [Abstract] [Full Text] [Related]
18. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms]. Guo GF, Yang AK, Xie RH, Chen ZH, Wu QL, Ou SM, Liu WW, Xia LP, Chen MY, Zhang JX, Wu JH. Ai Zheng; 2004 Nov 15; 23(11 Suppl):1546-50. PubMed ID: 15566677 [Abstract] [Full Text] [Related]
19. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PW, Benjamin RS, Pollock RE. Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1173-80. PubMed ID: 17689031 [Abstract] [Full Text] [Related]